Purchases and Sales Made in Q1 2024 in Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP) during Q1 2024. The information is specifically focused on institutions that hold shares of Adaptimmune Therapeutics PLC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-67.6K- 15.32% |
$47.3K - $118K
|
373K
$205K
|
|
|
Apr 15, 2024
Q1 2024
|
Key Client Fiduciary Advisors, LLC
|
SELL
|
- |
-68K- 20.19% |
$47.6K - $119K
|
269K
$148K
|
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-131K- 12.48% |
$91.4K - $228K
|
915K
$503K
|
|
|
May 03, 2024
Q1 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-139K- 27.25% |
$97K - $243K
|
370K
$204K
|
|
|
May 15, 2024
Q1 2024
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-182K- 1.66% |
$128K - $319K
|
10.8M
$5.93M
|
|
|
May 14, 2024
Q1 2024
|
Long Focus Capital Management, LLC
San Juan, PR |
SELL
|
- |
-1.4M- 11.6% |
$982K - $2.45M
|
10.7M
$5.88M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.58M- 80.92% |
$1.11M - $2.77M
|
373K
$205K
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.58M- 80.92% |
$1.11M - $2.77M
|
373K
$205K
|
|
|
May 15, 2024
Q1 2024
|
Tang Capital Management LLC
San Diego, CA |
SELL
|
- |
-2.94M- 67.1% |
$2.06M - $5.15M
|
1.44M
$794K
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-3.16M- 92.83% |
$2.21M - $5.52M
|
244K
$134K
|